Skip to main content

Advertisement

Table 2 Number and percentage of patients meeting the threshold measure and the clinical action measure

From: Clinical action measures improve the reliability of feedback on quality of care in diabetes centres: a retrospective cohort study

Diabetes type Type 1   Type 2  
(value) (n) (value) (n)
Threshold measure
 Below target value     
  LDL index value     
   Total, patients (%) 342 (60.2) 568 696 (63.0) 1105
   With CV history (LDL < 70 mg/dl), patients (%) 15 (31.9) 47 130 (39.5) 329
   Without CV history (LDL < 100 mg/dl), patients (%) 327 (62.8) 521 566 (72.9) 776
  non-HDL index value     
   Total, patients (%) 870 (70.5) 1234 1349 (61.7) 2187
   With CV history (non-HDL < 100 mg/dl), patients (%) 46 (51.1) 90 285 (41.9) 680
   Without CV history (non-HDL < 130 mg/dl), patients (%) 824 (72.0) 1144 1064 (70.6) 1507
Clinical action measure
 Treatment and contraindication status     
  LDL index value     
   LDL ≥ 70 mg/dl, patients     
    Treatment initiation or intens. [init.] 3 [3]   27 [23]  
    Contraindication 2   4  
   LDL ≥ 100 mg/dl, patients     
    Treatment initiation or intens. [init.] 23 [22]   26 [23]  
    Contraindication 2   5  
  non-HDL index value     
   non-HDL ≥ 100 mg/dl, patients     
    Treatment initiation or intens. [init.] 3 [3]   51 [36]  
    Contraindication 2   18  
   non-HDL ≥ 130 mg/dl, patients     
    Treatment initiation or intens. [init.] 42 [40]   53 [46]  
    Contraindication 2   3  
 Total     
  LDL index value     
   Total, patients (%) 372 (65.5) °   758 (68.6) °  
   With CV history, patients (%) 20 (42.5) $   161 (48.9) °  
   Without CV history, patients (%) 352 (67.6) °   597 (76.9) °  
  non-HDL index value     
   Total, patients (%) 919 (74.5) °   1474 (67.4) °  
   With CV history, patients (%) 51 (56.7) °   354 (52.1) °  
   Without CV history, patients (%) 868 (75.9) °   1120 (74.3) °  
  1. The denominator is represented by (n). The target of the index value for patients with cardiovascular history (defined as the presence of a MI, CABG, PCI, TIA or CVA) is lower than for those without cardiovascular history. Data are represented for the total number of type 1 or type 2 diabetes patients, as well as in the absence or presence of cardiovascular history. The proportion with an index value equal to or above the threshold, but with a recorded treatment initiation or intensification, or with a recorded contraindication for treatment intensification or initiation, is represented as number of patients. Statistical significance between the percentage of patients meeting the threshold measure and the clinical action measure was tested by the χ2-test: p < 0.001 (°), p < 0.01 ($) and p < 0.05 (*) vs. threshold measure